1. Autophagy inhibition induces the repolarisation of tumour-associated macrophages and enhances chemosensitivity of laryngeal cancer cells to cisplatin in mice

   • Ying Guo
   • Yufang Feng
   • Xinliang Pan

   Original Article 22 October 2019 Pages: 1909 - 1920

   

2. Pembrolizumab for anaplastic thyroid cancer: a case study

   • Marra Jai Aghajani
   • Adam Cooper
   • Tara Laurine Roberts

   Original Article 22 October 2019 Pages: 1921 - 1934

   

3. Regulatory T cells induce CD4⁻ NKT cell anergy and suppress NKT cell cytotoxic function

   • Fumie Ihara
   • Daiju Sakurai
   • Yoshitaka Okamoto

   Original Article 22 October 2019 Pages: 1935 - 1947

   

4. Combining alpha radiation-based brachytherapy with immunomodulators promotes complete tumor regression in mice via tumor-specific long-term immune response

   • Vered Domankevich
   • Adi Cohen
   • Yona Keisari

   Original Article Open access 22 October 2019 Pages: 1949 - 1958

   

5. Activated hepatic stellate cells regulate MDSC migration through the SDF-1/CXCR4 axis in an orthotopic mouse model of hepatocellular carcinoma

   • Yaping Xu
   • Fei Fang
   • Wenxiu Zhao

   Original Article 23 October 2019 Pages: 1959 - 1969

   

6. Identification of prognostic genes in the acute myeloid leukemia immune microenvironment based on TCGA data analysis

   • Haimeng Yan
   • Jianwei Qu
   • Zhen Cai

   Original Article 24 October 2019 Pages: 1971 - 1978

   

7. Preclinical development of T-cell receptor-engineered T-cell therapy targeting the 5T4 tumor antigen on renal cell carcinoma

   • Yuexin Xu
   • Alicia J. Morales
   • Scott S. Tykodi

   Original Article Open access 04 November 2019 Pages: 1979 - 1993

   

8. Predominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunity

   • Aurobind Vidyarthi
   • Tapan Agnihotri
   • Javed N. Agrewala

   Original Article 05 November 2019 Pages: 1995 - 2004

   

9. Serum very long-chain fatty acid-containing lipids predict response to immune checkpoint inhibitors in urological cancers

   • Andreas Mock
   • Stefanie Zschäbitz
   • Carsten Grüllich

   Original Article 07 November 2019 Pages: 2005 - 2014

   

10. Tumor genetic alterations and features of the immune microenvironment drive myelodysplastic syndrome escape and progression

    • Paola Montes
    • Mónica Bernal
    • Francisca Hernández

    Original Article 08 November 2019 Pages: 2015 - 2027

    

11. ISG15 pathway knockdown reverses pancreatic cancer cell transformation and decreases murine pancreatic tumor growth via downregulation of PDL-1 expression

    • Julian Burks
    • Alia Fleury
    • Jill P. Smith

    Original Article 11 November 2019 Pages: 2029 - 2039

    

12. PD-1⁺ TIGIT⁺ CD8⁺ T cells are associated with pathogenesis and progression of patients with hepatitis B virus-related hepatocellular carcinoma

    • Xiaoli Liu
    • Mengge Li
    • Zhiyun Yang

    Original Article 12 November 2019 Pages: 2041 - 2054

    

13. Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma

    • Bettina Langhans
    • Hans Dieter Nischalke
    • Ulrich Spengler

    Original Article 13 November 2019 Pages: 2055 - 2066

    

14. Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response

    • Yangyang Qi
    • Yuan Chang
    • Weijuan Zhang

    Original Article 12 November 2019 Pages: 2067 - 2080

    

15. Histone deacetylase inhibition promotes intratumoral CD8⁺ T-cell responses, sensitizing murine breast tumors to anti-PD1

    • Tyler R. McCaw
    • Mei Li
    • Troy D. Randall

    Original Article 12 November 2019 Pages: 2081 - 2094